Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of T-817MA in Hepatic Impairment
NCT02693197Phase 1Completed
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Feb 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of edonerpic in Alzheimer's disease (AD) (6 arms), sponsored by FUJIFILM Toyama Chemical. Primary endpoints: Plasma concentrations of T-817 and T-817M5 at 8 days, Area under the plasma concentration time curve at 8 days and 7 more. Started Feb 2016; status: completed.
02
Drugs
edonerpic
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02693197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02693197.